Large-scale exercise of the 70th stock acquisition rights occurred. At the start of the month, the number of shares to be delivered was 8,024,000 shares; exercised rights amounted to 80,240 units (16.7% of the total issued 480,000 units); as of November 5, unexercised units decreased to 328,460 units. The relevant period is November 2\u20135, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4582","jir_company_name":"SymBio Pharmaceuticals Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4582-20261106-01.pdf","jir_short_summary":"Large-scale exercise of the 70th stock acquisition rights occurred. At the start of the month, the number of shares to be delivered was 8,024,000 shares; exercised rights amounted to 80,240 units (16.7% of the total issued 480,000 units); as of November 5, unexercised units decreased to 328,460 units. The relevant period is November 2\u20135, 2026.","jir_summary":"### Key Points\nA large-scale exercise of the 70th stock acquisition rights issued by third-party allotment occurred. From November 2 to November 5, the total number of shares to be delivered exceeded 800,000 shares; the number of rights actually exercised was 80,240 units, and unexercised units decreased to 328,460 units. During the relevant period, the total number of issued shares was 87,378,960 shares and treasury stock amounted to 91,394 shares.\n\n### Market Impact and Outlook\nThere is potential dilution from the exercise of stock acquisition rights; refer to the main text for the net effect on shares after transfer. It is necessary to reconcile with past disclosed materials and monitor future exercise activity and the movement of treasury stock.","jir_financial_highlights":"Number of shares to be delivered: 8,024,000 shares (Unknown)\nNumber of stock acquisition rights exercised: 80,240 units (YoY Unknown)\nNumber of unexercised stock acquisition rights: 328,460 units (Month-end change -80,240 units (movement))\nTotal number of issued stock acquisition rights: 480,000 units (Unknown)","jir_category":"","jir_hashtags":"#SymBioPharmaceuticalsLtdDeclinesToComment #StockAcquisitionRightsExercise","jir_key_figures":"Number of shares to be delivered: 8,024,000 shares\nNumber of unexercised stock acquisition rights: 328,460 units\nTotal number of issued stock acquisition rights: 480,000 units","jir_meta_title":"SymBio Pharmaceuticals Limited \u2014 Notice of Large-Scale Exercise of Stock Acquisition Rights | November 2026","jir_meta_description":"SymBio Pharmaceuticals Limited announced a large-scale exercise of the 70th stock acquisition rights issued by third-party allotment. Number of shares to be delivered: 8,024,000 shares; rights exercised: 80,240 units; unexercised: 328,460 units. Monitor future share movements.","jir_og_title":"SymBio Pharmaceuticals Limited \u2014 Notice of Large-Scale Exercise of Stock Acquisition Rights | November 2026","jir_og_description":"Announcement of a large-scale exercise of stock acquisition rights. Shares to be delivered: 8,024,000 shares; rights exercised: 80,240 units; unexercised: 328,460 units. Watch future share movement.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60013,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-144031","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n